Alkermes (ALKS) Total Debt (2011 - 2026)

Alkermes' (ALKS) quarterly Total Debt came in at $1.5 billion in Q1 2026, up 422.93% on a QoQ basis from $288.8 million in Q3 2024.

Alkermes (ALKS) Total Debt (2011 - 2026) Analysis & Trends

Alkermes (ALKS) has 15 years of Total Debt data on file, last reported at $1.5 billion in Q1 2026.

  • On a quarterly basis, Total Debt changed N/A year-over-year to $1.5 billion in Q1 2026; TTM through Mar 2026 was $1.5 billion, a N/A change from a year earlier, with the FY2023 full-year figure at $290.7 million, down 0.87% from the prior year.
  • Total Debt for Q1 2026 stood at $1.5 billion, up from $288.8 million in the prior quarter.
  • Over the last five years, Total Debt for ALKS reached as high as $1.5 billion in Q1 2026 and fell as low as $288.8 million in Q3 2024.
  • Historically, Total Debt has averaged $393.5 million across 4 years, with a median of $292.3 million in 2023.
  • Across the five-year window, Total Debt decreased 0.85% in 2022 and declined 0.87% in 2024, its largest moves.
  • Year by year, Total Debt stood at $293.3 million in 2022, then slipped by 0.87% to $290.7 million in 2023, then fell by 0.66% to $288.8 million in 2024, then surged by 422.93% to $1.5 billion in 2026.
  • Per Business Quant data, the three most recent Total Debt figures were $1.5 billion in Q1 2026, $288.8 million in Q3 2024, and $289.5 million in Q2 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Debt (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - 11.45 Bn
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 16.63 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 9.05 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 28.76 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn -
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - 7.15 Bn
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 14.34 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn -
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 3.81 Bn
10 Alkermes 9.72 Bn 9.21 Bn 331.33 Mn 1.51 Bn

Historic Data

Download Data
DateValue
Mar 31, 2026 1.51 Bn
Sep 30, 2024 288.82 Mn
Jun 30, 2024 289.46 Mn
Mar 31, 2024 290.10 Mn
Dec 31, 2023 290.73 Mn
Sep 30, 2023 291.37 Mn
Jun 30, 2023 292.00 Mn
Mar 31, 2023 292.64 Mn
Dec 31, 2022 293.27 Mn
Sep 30, 2022 293.90 Mn
Jun 30, 2022 294.54 Mn
Mar 31, 2022 295.17 Mn
Dec 31, 2021 295.80 Mn
Sep 30, 2021 296.44 Mn
Jun 30, 2021 297.07 Mn
Mar 31, 2021 297.70 Mn
Dec 31, 2020 274.96 Mn
Sep 30, 2020 275.51 Mn
Jun 30, 2020 276.05 Mn
Mar 31, 2020 276.59 Mn